ANI Pharmaceuticals | ANIP - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
AbbVie USD 6.57B 2.82B 2026-06
ANI Pharmaceuticals USD 360.21M 49.04M 2026-06
Aurora Cannabis CAD 64.69M 8.33M 2026-03
Canopy Growth CAD 364.68M 6.64M 2026-03
Eli Lilly USD 8.95B 3.67B 2026-06
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Heron Therapeutics USD 20.72M 5.4M 2026-06
Hikma Pharmaceutical USD 217M 19M 2025-12
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Nektar Therapeutics USD 149.58M 134.46M 2026-03
Novartis USD 6.88B 2.68B 2026-03
Omeros USD 1.9M 2.36M 2025-06
Perrigo USD 357.2M 174.4M 2026-03
Sun Pharmaceuticals INR 97.71B 15.61B 2026-03
Teva Pharmaceutical Industries USD 3.74B 185M 2026-03